登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
NACRES:
NA.85
UNSPSC Code:
41171607
Manufacturer/tradename:
NutriSelect® Plus
Ph:
7.2±0.2 (25 °C)
Form:
powder
Suitability:
anaerobic bacteria, bacteria (Fastidous organisms), nonselective for Bacteroides spp., nonselective for Clostridium spp., nonselective for Streptococcus spp.
Application(s):
clinical testing
food and beverages
sterility testing, microbiology
food and beverages
sterility testing, microbiology
sterility
non-sterile
Quality Level
form
powder
shelf life
limited shelf life, expiry date on the label
packaging
pack of 500 g
manufacturer/tradename
NutriSelect® Plus
pH
7.2±0.2 (25 °C)
application(s)
clinical testing
food and beverages
sterility testing, microbiology
suitability
anaerobic bacteria, bacteria (Fastidous organisms), nonselective for Bacteroides spp., nonselective for Clostridium spp., nonselective for Streptococcus spp.
Application
用于测试生物制品的无菌性。
Preparation Note
将40.5 g 布氏硫乙醇酸盐培养基悬浮于1000ml 蒸馏水中。 加热煮沸至完全溶解培养基。根据需要分装在试管或合适的容器中,并在15 磅的压力(121°C)下高压灭菌15 分钟。注意:如果上层超过上三分之一的培养基呈绿色,可以通过在水浴或自由流动的蒸汽上加热来恢复培养基一次,直到绿色消失。
Other Notes
成分(g/L)
蛋白胨 10.00
牛肉浸出液 17.50
葡萄糖 5.00
氯化钠 5.00
磷酸氢二钾 2.00
硫乙醇酸钠 0.50
亚甲基蓝 0.002
琼脂 0.50
蛋白胨 10.00
牛肉浸出液 17.50
葡萄糖 5.00
氯化钠 5.00
磷酸氢二钾 2.00
硫乙醇酸钠 0.50
亚甲基蓝 0.002
琼脂 0.50
我们现提供两种类型的培养基:GranuCult®优质颗粒状培养基和NutriSelect®高性价比粉末状培养基,满足用户不同层次的需求。
商标后的品级称号basic(基础)、plus(加强)或prime(特级)代表产品的不同质控水平,从基础的质控到标准质控加强版到全面合规的特级质控水平。
商标后的品级称号basic(基础)、plus(加强)或prime(特级)代表产品的不同质控水平,从基础的质控到标准质控加强版到全面合规的特级质控水平。
Legal Information
GRANUCULT is a registered trademark of Merck KGaA, Darmstadt, Germany
NutriSelect is a registered trademark of Merck KGaA, Darmstadt, Germany
signalword
Warning
hcodes
Hazard Classifications
Skin Sens. 1
存储类别
11 - Combustible Solids
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
法规信息
动物来源培养基
此项目有
商品
Streptococci- Overview of Detection, Identification, Differentiation and Cultivation Techniques
链球菌 — 检测、鉴定、分化和培养技术概述
Xuyun Gu et al.
Experimental and therapeutic medicine, 16(1), 171-177 (2018-06-14)
Sepsis with severe systemic inflammation remains a great challenge for the intensive care unit in clinics. Although biomarkers have been identified to diagnose, monitor and predict these syndromes, novel therapeutic approaches are required for the amelioration of symptoms of sepsis
National Institutes of Health Bulletin (1941)
Justin R Kingery et al.
Basic research in cardiology, 112(2), 19-19 (2017-02-27)
In the failing heart, iNOS is expressed by both macrophages and cardiomyocytes. We hypothesized that inflammatory cell-localized iNOS exacerbates left ventricular (LV) remodeling. Wild-type (WT) C57BL/6 mice underwent total body irradiation and reconstitution with bone marrow from iNOS
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| B2551-500G | 04061833426937 |
